Literature DB >> 3275562

How antibodies work: focus on Fc receptors.

H Metzger1, J P Kinet.   

Abstract

It is increasingly appreciated that the part of an antibody not involved in the binding of antigen--the Fc region--plays an important biological role. It activates a variety of receptors not only on so-called effector cells such as macrophages and granulocytes, but also on lymphocytes, and it can thereby modulate the immune response itself. Over the past 2 years much new information has been gained about the structure of such receptors, in large part through molecular genetics. In this review we describe the structure and some aspects of the function of the most complicated of the cellular Fc receptors so far identified: the receptor with high affinity for immunoglobulin E (IgE) on mast cells. The structure of its IgE-binding chain is strikingly similar to the corresponding polypeptide of an immunoglobulin G receptor. Like the latter and like a receptor that binds polymeric immunoglobulin, segments of the protein resemble immunoglobulin sequences. It is surprising that other IgE-binding proteins that putatively serve related functions have completely different structures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275562     DOI: 10.1096/fasebj.2.1.3275562

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D.

Authors:  S M Tamma; A R Amin; F D Finkelman; Y W Chen; G J Thorbecke; R F Coico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 2.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

3.  Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.

Authors:  B Bettler; R Maier; D Rüegg; H Hofstetter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.

Authors:  Kristen E Funk; Hilda Mirbaha; Hong Jiang; David M Holtzman; Marc I Diamond
Journal:  J Biol Chem       Date:  2015-06-30       Impact factor: 5.157

Review 5.  Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies.

Authors:  Hao Zhang; Weidong Cui; Michael L Gross
Journal:  FEBS Lett       Date:  2013-11-26       Impact factor: 4.124

6.  Non-Faradaic Electrochemical Detection of Exocytosis from Mast and Chromaffin Cells Using Floating-Gate MOS Transistors.

Authors:  Krishna Jayant; Amit Singhai; Yingqiu Cao; Joshua B Phelps; Manfred Lindau; David A Holowka; Barbara A Baird; Edwin C Kan
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

Review 7.  Brownian Motion at Lipid Membranes: A Comparison of Hydrodynamic Models Describing and Experiments Quantifying Diffusion within Lipid Bilayers.

Authors:  Stephan Block
Journal:  Biomolecules       Date:  2018-05-22

8.  IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.

Authors:  Haritha L Desu; Melanie Plastini; Placido Illiano; Helen M Bramlett; W Dalton Dietrich; Juan Pablo de Rivero Vaccari; Roberta Brambilla; Robert W Keane
Journal:  J Neuroinflammation       Date:  2020-05-04       Impact factor: 8.322

Review 9.  Significance of Receptor Mobility in Multivalent Binding on Lipid Membranes.

Authors:  Diana Morzy; Maartje Bastings
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-28       Impact factor: 16.823

Review 10.  The Immune Microenvironment of Breast Cancer Progression.

Authors:  Helen Tower; Meagan Ruppert; Kara Britt
Journal:  Cancers (Basel)       Date:  2019-09-16       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.